JENNIFER OBANA: Open Payments
NPI 1114368628 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 21 payments from 11 companies in 2025. Trend: 2023 $868 · 2024 $637 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| Lilly USA, LLC | 4 | $101 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Boston Scientific Corporation | 1 | $56 |
| Medtronic, Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $30 |
| Seqirus USA Inc | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, WaveWriter Alpha Prime 16, AREXVY, SYMPLICITY G3, Wegovy, SHINGRIX, Flucelvax.
Industry payments across CA — which companies pay providers there.
